頁籤選單縮合
題 名 | 高血脂症的航醫考量與缺點免計=Aeromedical Concerns of Hypercholesterolemia |
---|---|
作 者 | 張喬翔; 李笙平; 羅羿凡; 林宗泰; 吳佳蕙; 謝伯謙; | 書刊名 | 中華民國航空醫學暨科學期刊 |
卷 期 | 29:1/2 2015.12[民104.12] |
頁 次 | 頁61-67 |
分類號 | 412.85 |
關鍵詞 | 高血脂; 動脈粥狀硬化; 航醫考量; 缺點免計; Hyperlipidemia; Atherosclerosis; Aeromedical consideration; Waiver; |
語 文 | 中文(Chinese) |
中文摘要 | 高血脂已被證實與動脈硬化疾病,有著密切的關連,而動脈硬化疾病又會進而增加腦血管以及心血管事件的風險,飛行任務的特性時常使飛行員暴露在一個高生理壓力的情形,而心血管及腦血管事件的發生更是攸關飛機組員的安危以及任務的成敗。在此積極治療高血脂症有其必要。2013年的美國心臟醫學會提出適合使用膽固醇合成抑制劑治療的4大族群,並不以過去低密度膽固醇數值為指標而改以心血管事件風險預測為主來作為評估高血脂患者治療的指引,美國空軍的教範也依照美國心臟醫學治療指引做了修改。本文將比較我國目前的教範與美軍的教範,同時探討高血脂對飛航安全的影響與其缺點免計考量。 |
英文摘要 | Cerebrovascular and cardiovascular events are threats to air crew health, flight safety as well as mission success. Hyperlipidemia is a proven risk factor of atherosclerosis, patients with hyperlipidemia have higher risks of cerebrovascular and cardiovascular events. The 2013 ACA/AHA Guideline, instead of using low-density lipoprotein as main criteria for treatment, includes clinical symptoms, diabetes and the 10-year atherosclerotic cardiovascular disease risk as treatment criteria. The hyperlipidemia waiver regulations in American Air Force Waiver Guide have been modified according to the new ACA/AHA guideline. In current article, the authors discussed the aeromedical consideration of hyperlipidemia and also compared the differences in waiver criteria between ROC and US Air Forces. |
本系統中英文摘要資訊取自各篇刊載內容。